HD-OPM Archive

Creatine, taurine, NMN and other longevity supplements

A tiered look at which popular longevity supplements (taurine, NAD precursors such as NR and NMN, niacin, creatine, spermidine, urolithin A, glycine and others) have human evidence, which rest mainly on mouse studies, and how the group's admins weigh them.

17 min read54 group posts cited48 studies discussed3 chartsEvidence through Nov 2026AI Summary of posts by Louis Nervegna and Gokhan Can
Key takeaways
  • Taurine has the most human trial data of the group's longevity supplements. A meta-analysis of randomized trials using 0.5-6 g/day found systolic blood pressure about 4 mmHg lower, triglycerides 18.3 mg/dL lower and LDL 6.5 mg/dL lower, so the effects are real but modest.1
  • The idea that taurine falls with age and that restoring it slows aging is contested. A large longitudinal study found levels do not consistently decline and often rise, and a 2026 Yale study found they increase with age and may be a defensive response.234
  • Whole-blood NAD+ stayed stable with age across seven human cohorts, so commercial NAD blood tests are described as meaningless; NR and NMN raise NAD but there is no convincing clinical evidence they slow human aging.56
  • Creatine at 20 g/day raised brain creatine by 11% in a small open-label Alzheimer's pilot (20 people, 8 weeks); that tested feasibility, not whether it helps.7
  • Urolithin A, spermidine, glycine and vanadyl sulfate mostly rest on animal data, with observational data for dietary spermidine (829 people followed 20 years) and one 74-person glycine trial in type 2 diabetes.891011
  • A systematic review of 884 randomized trials found moderate-to-high quality evidence for outcomes mainly with omega-3, folic acid and coenzyme Q10, while vitamins C, D, E and selenium showed no effect on cardiovascular disease and beta-carotene did harm.12
In this summary
  1. How to read longevity-supplement claims
  2. Taurine
  3. NAD, NR, NMN and niacin
  4. Creatine
  5. Spermidine
  6. Urolithin A
  7. Glycine, glutathione and other amino acids
  8. Other products that appear in the group
  9. What this means for you
  10. Frequently asked questions
  11. The evidence behind this summary

Most "longevity supplements" have far more evidence in worms and mice than in people. In the group's posts, taurine comes closest to having a human evidence base, with several meta-analyses of randomized trials showing small improvements in blood pressure, triglycerides and insulin resistance.11314 The central claim behind its fame, that low taurine drives aging and topping it up slows aging, is disputed.24

For NAD boosters (NR and NMN), spermidine, urolithin A, glycine and similar products, the group's admins mostly describe the evidence as promising but preclinical, or as changing a biomarker without proof of clinical benefit.51015 Creatine has a small human signal in Alzheimer's disease and a mixed preclinical picture in cancer.716

This summary organizes the group's posts by how strong the evidence behind each supplement is. It is educational, not medical advice; Louis Nervegna repeatedly stresses words like "might" and the admins recommend discussing any supplement with your doctor.417

4 mmHglower systolic blood pressure with taurine (0.5-6 g/day) in a meta-analysis of randomized trials1
7 cohortsin which whole-blood NAD+ stayed stable with age6
11%rise in brain creatine on 20 g/day in a 20-person Alzheimer's feasibility pilot7
884 trialspooled in a review: omega-3, folic acid and CoQ10 helped, beta-carotene harmed12

How to read longevity-supplement claims

Four kinds of evidence appear in the posts, and they carry very different weight.

  • Randomized human trials and meta-analyses (for example taurine and glycine in diabetes). They can show an effect on a measured marker, but most last weeks to months and track blood tests, not heart attacks or lifespan.1918
  • Observational human data (for example dietary spermidine and mortality). These show associations, not proof that a supplement would do the same.8
  • Mouse and cell studies (urolithin A, vanadyl sulfate, NAD boosting). Louis flags these as mouse data, "not evidence for humans."1119
  • Biomarker changes. A shared commentary on NAD puts it bluntly: "Changing a biomarker is not the same as improving health."5

A large systematic review quoted by Louis shows how different the landscape looks when trials are pooled. In 884 randomized trials of 27 micronutrients (883,627 participants), omega-3 reduced cardiovascular mortality (RR 0.93), heart attack (RR 0.85) and coronary events (RR 0.86); folic acid reduced stroke (RR 0.84); and coenzyme Q10 reduced all-cause mortality (RR 0.68, 95% CI 0.49-0.94). Vitamins C, D, E and selenium showed no effect on cardiovascular disease or type 2 diabetes, and beta-carotene increased all-cause mortality (RR 1.10), cardiovascular mortality (RR 1.12) and stroke (RR 1.09).12 The quoted text does not mention taurine, creatine, NMN or the other products below, which fits the point that the trendiest supplements are not necessarily the best studied.

Pooled trials: a few supplements helped, one harmedRelative risk versus control in a systematic review of 884 randomized trials (27 micronutrients, 883,627 participants)
interval clear of 195% confidence interval
Omega-3: cardiovascular death0.93 (0.88–0.97)
Omega-3: heart attack0.85 (0.78–0.92)
Omega-3: coronary heart disease events0.86 (0.80–0.93)
Folic acid: stroke0.84 (0.72–0.97)
Coenzyme Q10: death from any cause0.68 (0.49–0.94)
Beta-carotene: death from any cause1.10 (1.05–1.15)
Beta-carotene: cardiovascular death1.12 (1.06–1.18)
Beta-carotene: stroke1.09 (1.01–1.17)
Vitamins C, D, E and selenium showed no effect on cardiovascular disease or type 2 diabetes. Taurine, creatine, NMN and the other products in this summary were not in the quoted results. Source: 12
Show data
Relative risk (log scale)95% CI
Omega-3: cardiovascular death0.930.88–0.97
Omega-3: heart attack0.850.78–0.92
Omega-3: coronary heart disease events0.860.80–0.93
Folic acid: stroke0.840.72–0.97
Coenzyme Q10: death from any cause0.680.49–0.94
Beta-carotene: death from any cause1.101.05–1.15
Beta-carotene: cardiovascular death1.121.06–1.18
Beta-carotene: stroke1.091.01–1.17

Taurine

What it is

Taurine is a sulfur-containing amino-acid-like molecule that the body makes from cysteine and that is found in food. It is concentrated in the heart, brain, retina and skeletal muscle, and is described as conditionally essential because the body's production does not always meet demand.11720

The aging debate

In 2023, Columbia University researchers reported that taurine deficiency drives aging in animals, with work spanning worms, mice, monkeys and humans. Louis highlighted it with the caveat that taurine "might" be an aging intervention and appears reasonably safe.17 The Columbia mouse work gave a lifespan extension of 10-12% in mice, according to Gokhan Can's summary of the research.21

Then came a challenge. A large longitudinal study from Rafael de Cabo's group at the NIA, described by Louis as published in Nature, found that taurine levels do not decline with age in humans, monkeys or mice. Louis noted that most of its data were collected longitudinally, whereas much of the Columbia data were cross-sectional. He also pointed out that unchanged levels do not mean supplementation has no value, because the Columbia paper included interventions in animals, and he predicted a fight "like what happened with resveratrol."2 Another shared summary described the same finding as taurine often rising with age, especially in women, with individual differences outweighing age trends, and concluded taurine is not a reliable biomarker of aging in healthy people.3

The NIA study's summary figure: across human cohorts, monkeys and mice, effect sizes for the change in circulating taurine with age sit mostly to the right of zero (an increase), levels vary widely between individuals, and links to health outcomes are inconsistent.
The NIA study's summary figure: across human cohorts, monkeys and mice, effect sizes for the change in circulating taurine with age sit mostly to the right of zero (an increase), levels vary widely between individuals, and links to health outcomes are inconsistent.3

A 2026 study from Yale in Cell offers a possible reconciliation. Serum from people aged 20-40 and 60-99 showed that taurine actually increased with age, which led the researchers to suspect this is a failed attempt to damp inflammation.4 In macrophages (immune cells), inflammatory triggers made the cells release up to 80% of their taurine, which helped switch on the NLRP3 inflammasome (a protein complex that drives inflammation). Restoring taurine suppressed that activation, and in older mice raising taurine improved grip strength, coordination, some glucose measures and inflammatory markers.2223 Louis's reading is that taurine may rise with age as a defense against "inflammaging," but he labels this unproven and preclinical.4

Dose: what mice imply

Louis worked through the dose question for the Columbia mouse study, which used 500-1000 mg/kg. Applying FDA allometric scaling (dividing by 12.3 to account for mouse metabolism) gives about 40.7-81.3 mg/kg, or roughly 2.8-5.7 g for a 70 kg person. He calls this a crude starting point for human trials, on the high end of doses used in prior human studies, and emphasizes "might."24 Gokhan, who took taurine personally, wrote that he suspects he overdosed it in the past.21

Human trials

The most useful evidence is on cardiometabolic markers.

  • Meta-analysis (Tzang 2024, Nutrition & Diabetes). Randomized trials using 0.5-6 g/day showed, against placebo, systolic blood pressure down 4 mmHg, diastolic down 1.5 mmHg, triglycerides down 18.3 mg/dL, total cholesterol down 8.3 mg/dL, LDL down 6.5 mg/dL, fasting glucose down 5.9 mg/dL, HOMA-IR (an insulin-resistance index) down 0.69, fasting insulin down 1.5 mU/L, and an HbA1c trend of -0.34%. Louis summarized that taurine "modestly improves multiple major risk factors."1
  • Meta-analysis of 34 trials (Nutrition Reviews, 2026). In 1,394 participants taurine improved several cardiometabolic markers versus placebo or control, though the post does not list the specific markers.13
  • Meta-analysis in overweight and obesity (Nutrients, 2024; 9 trials). Fasting insulin, triglycerides and total cholesterol fell. BMI dropped 1.14 kg/m2 in overweight adults, HbA1c and HOMA-IR improved only in people with obesity, and 3 g/day was linked to HbA1c down 0.37 points and fasting glucose down 7.14 mg/dL. The summary cautions that results do not show everyone with overweight or obesity should take 3 g daily.14
  • Type 2 diabetes RCT (2022). In 120 people on a low-calorie diet, 3 g/day for 8 weeks lowered insulin, HOMA-IR, inflammation markers (TNF, hs-CRP), an oxidative-stress marker (MDA) and endothelial-dysfunction markers, but did not improve lipids, HbA1c or fasting glucose.18
  • Type 1 diabetes crossover trial (2010). 1.5 g/day for 2 weeks returned arterial stiffness and brachial artery flow-mediated dilation (FMD) to control levels in young men with type 1 diabetes. It was tiny (9 diabetics, 10 controls).25
Taurine's effects on blood markers are modestAverage change versus placebo in a meta-analysis of randomized trials using 0.5–6 g/day of taurine (Tzang 2024)
Triglycerides−18.3 mg/dL
Total cholesterol−8.3 mg/dL
LDL cholesterol−6.5 mg/dL
Fasting glucose−5.9 mg/dL
The same analysis found systolic blood pressure 4 mmHg and diastolic 1.5 mmHg lower, and HOMA-IR down 0.69. These are risk-marker changes, not outcomes. Source: 1
Show data
Change (mg/dL)
Triglycerides−18.3 mg/dL
Total cholesterol−8.3 mg/dL
LDL cholesterol−6.5 mg/dL
Fasting glucose−5.9 mg/dL

Results are not uniform. A prediabetic trial listed in Gokhan's long evidence summary found that 8 weeks of taurine did not improve insulin sensitivity or lipids. Most of the other support in that summary is animal or observational, such as higher taurine intake correlating with lower coronary disease and reduced atherosclerosis in rabbits.26 A promotional post shared in the group claims blood pressure and insulin benefits but cites no specific study, so it is better treated as marketing than evidence.27

Taurine and cancer headlines

A shared explainer pushes back on headlines that "taurine fuels cancer." The underlying Nature paper used genetically engineered mouse models of leukemia, where leukemia cells upregulated a taurine transporter and used locally made taurine; blocking taurine transport slowed the disease. The explainer stresses that this did not test dietary taurine, supplements or energy drinks.20

NAD, NR, NMN and niacin

NAD+ is a cellular molecule that sirtuin proteins (SIRT1, SIRT6) depend on, and vitamin B3 forms (niacin, nicotinamide, NR and NMN) all raise it.28

Blood NAD tests are not meaningful

A Nature Metabolism study quantified NAD+ in seven independent human cohorts by mass spectrometry. Whole-blood NAD+ stayed stable with age and with lifestyle interventions, and only changed with nicotinamide riboside supplementation.615 Louis says the blood level mainly reflects recent vitamin B3 intake, calls it a useless biomarker, and argues that Charles Brenner has been vindicated; tissue NAD is what may matter, but no commercial test measures it.56 Louis adds that he takes his vitamin B3 anyway, "just like Brenner."6

Do NR and NMN work?

NR and NMN do raise circulating NAD+, but a shared reality check says there is still no convincing clinical evidence they slow human aging, extend lifespan or broadly improve healthspan, and calls for rigorous human trials.515 There are narrower human signals. In a 6-month trial in peripheral artery disease, NR improved six-minute walking distance, while placebo and NR plus resveratrol groups declined, per a FoundMyFitness summary Louis shared.29

Heart and arteries: conflicting animal signals

Animal data point in both directions. A 2025 mouse study found niacin reduced vascular calcification through SIRT1/SIRT6 activation, and Louis speculated that other B3 forms might act similarly, while cautioning it is an artificially engineered mouse model with unclear human relevance.28 Gokhan, by contrast, shared a 2025 Atherosclerosis paper in which NAD+ boosting increased plaque and inflammation in Apoe knockout mice, again with the note that nobody knows what happens in humans.30

Louis also reminds readers that niacin (nicotinic acid) failed to improve outcomes in two very large randomized trials when combined with maximum-dose statins, with more side effects than statins alone, and states that nicotinic acid should not be combined with high-dose statins.28

Non-heart uses of vitamin B3

Louis has posted several times on glaucoma. A 2020 randomized trial in 57 people with glaucoma gave nicotinamide at 1,500 mg daily for six weeks then 3,000 mg daily and reported improved inner retinal function; a phase 2 trial in 32 people combined nicotinamide with pyruvate and showed more improving visual-field locations than placebo.3132 An observational study found people with high eye pressure taking nicotinamide were about two-thirds less likely to be diagnosed with open-angle glaucoma, and a larger trial is underway.33 The summary says the doses were far higher than ordinary supplements and should not be attempted without an ophthalmologist, and that it does not replace pressure-lowering treatment.32 A small glioblastoma pilot using niacin reported 82% of 24 patients free of progression at six months, but used historical controls.34 None of this is about heart disease directly.

Creatine

The group's posts on creatine are few and mostly about the brain and cancer, not the heart.

  • Alzheimer's pilot. In an open-label study of 20 older adults (mean age 73) with probable Alzheimer's, 20 g/day of creatine monohydrate for 8 weeks raised brain creatine by 11% (measured by MR spectroscopy) and serum creatine by about 35%, with 90% compliance and no serious adverse events. It was a feasibility study, not an efficacy trial.7 A separate FoundMyFitness-sourced post reported nearly 5% improved cognition at the same dose and duration, and Louis framed it as "something to consider" for a loved one with Alzheimer's.35 The cognition claim comes from an interview summary rather than a cited paper, and the post does not say whether it comes from the same pilot.
  • Cancer. The evidence is mixed. A summary notes that animal and cell models showed creatine increasing metastatic behavior and worsening survival, but higher dietary creatine has been linked to lower cancer risk in a limited study, and a randomized trial giving creatine to people with malignant cancer found no meaningful survival difference, although it was not designed to test that. The poster advises people with cancer to talk with their oncology team.16 A newer UCLA mouse study suggested creatine may boost cancer-fighting immune cells and slow tumor growth. Louis notes earlier preclinical work pointed the other way.36
  • Fatty liver. One animal study suggested creatine may help diet-related fatty liver but not alcohol-related fatty liver. Louis says it needs human replication.37

Spermidine

Spermidine is an autophagy-inducing polyamine (autophagy is the cell's recycling process) found in foods such as wheat germ, mushrooms, soy, aged cheese and natto. Gokhan's summary lists several mouse and rat studies, including a 2016 report that oral spermidine extended median lifespan and protected the heart in aged mice, a lifespan increase of about 25% in mice in a 2017 study, and a 2020 rat study that found no lifespan extension but other health benefits.838

The human data are observational. In a prospective study of 829 people aged 45-84 followed for 20 years, all-cause mortality across rising spermidine-intake tertiles was 40.5, 23.7 and 15.1 deaths per 1000 person-years, with each 1-SD higher intake linked to 24-26% lower mortality and about 70% lower risk of cognitive impairment.8 Spermidine supplementation is described as safe and well tolerated in older adults.8

Higher dietary spermidine, fewer deathsAll-cause deaths per 1,000 person-years by spermidine-intake third, 829 people aged 45–84 followed for 20 years
Lowest intake40.5
Middle intake23.7
Highest intake15.1
Observational: an association with food intake, not a supplement trial. Source: 8
Show data
Deaths per 1,000 person-years
Lowest intake40.5
Middle intake23.7
Highest intake15.1

Gokhan estimates a 50 g serving of natto has 5-13 mg of spermidine, and cites an association between natto consumption and 18% lower all-cause mortality.38 He and Louis also point to whole wheat (the germ) as a source, with Louis offering the "reproductive parts of plants" idea as biologically plausible but acknowledging that it sounds pseudoscientific and that the life-extension evidence is in rodents and lower animals.3940

Urolithin A

Urolithin A is a compound gut bacteria make from ellagitannins in pomegranate, walnuts and berries. About half of people produce it after eating pomegranate.101941 Louis calls it a mild mitochondrial stressor that triggers protective "mitohormesis," like statins and metformin, which is his opinion rather than a trial result.42

Heart-related findings are preclinical. A 2026 Science Advances study found urolithin A activated the heart-protective protein PKGIα, improved relaxation and reduced fibrosis in mice with heart failure with preserved ejection fraction (HFpEF), and also improved relaxation in engineered human heart tissue. Louis stresses human studies are lacking.10 Another newly published mouse study reported improvements of up to 80% in heart-function measures.19 One shared overview mentions human trials published in Nature Medicine, but the group's posts do not give their results, and Louis says most of the evidence is preclinical.41

Glycine, glutathione and other amino acids

  • Glycine. A 2008 randomized trial of 74 people with type 2 diabetes gave 5 g three times daily for 3 months. A1C fell, in the quoted example from 8.3 to 6.9, compared with placebo, with lower proinflammatory markers.9 A narrative review says glycine may be geroprotective and may help in acute heart attack, endothelial dysfunction and insulin resistance, and that it modestly extends lifespan in rodents; it is a review, not a trial.43 Gokhan reports that glycine "never helped me."21
  • Glutathione. Louis argues oral glutathione is probably a bad idea long term, because it is mostly broken down and can raise levels outside cells, interfering with redox signaling. He prefers Nrf2 activators (broccoli sprouts, turmeric) and enough cysteine and glycine. This is his reasoning, supported by skin-lightening anecdotes rather than trials.44
  • Gokhan's "metabolite cocktail." Gokhan describes taking AKG, L-arginine, beta-alanine, taurine and L-carnitine, mostly on animal data, and calls it a personal experiment rather than evidence of cardiovascular benefit.21

Other products that appear in the group

  • Vanadyl sulfate. A 2026 Nature Aging mouse study found it acts as a senolytic (kills senescent cells) and extended male mouse median lifespan by 7.4% when started late in life. The cohort was small (about 20 mice per group), the effect barely reached significance, and vanadium is toxic. Louis calls it mouse data, not human evidence.11
  • Nattokinase. In a 1,062-person clinical study, 10,800 FU/day improved carotid intima-media thickness, plaque size and lipids, while 3,600 FU/day was ineffective.45 Gokhan notes that nattokinase appears to act by inhibiting PAI-1, a marker linking clotting, inflammation, metabolic disorder and aging, and suggests high-dose nattokinase might be the safest option for that today; this is his view, and the PAI-1 findings he lists include preclinical work.46 His natto summary adds that doses above 8,000 FU/day may reverse coronary plaque progression, which is a hypothesis drawn from the same study.38
  • Aged garlic extract, gotu kola and pine bark. Small trials of garlic extract slowed coronary calcium progression, but two of the three used co-supplements.47 Louis says gotu kola plaque findings need larger, higher-quality studies.4849
  • Testosterone for "anti-aging." Louis warns there is no credible evidence of longevity benefit beyond treating diagnosed hypogonadism, citing an inverse-U relationship with mortality in 3,690 older men.5051
  • Magnesium and other basics. Louis argues magnesium form-specific claims are hype, with all forms absorbed, and a Rhonda Patrick summary describes widespread inadequate intake of magnesium and vitamin D.525354
The inverse-U curve Louis shared: in older men, the probability of dying was highest at the lowest calculated free testosterone, lowest around 200 pmol/L, and drifted up again at higher levels, with wide uncertainty at the top.
The inverse-U curve Louis shared: in older men, the probability of dying was highest at the lowest calculated free testosterone, lowest around 200 pmol/L, and drifted up again at higher levels, with wide uncertainty at the top.50

What this means for you

This is a summary of the group's discussion, not personal medical advice.

  • Treat "longevity" claims as hypotheses unless there is a randomized trial in humans measuring something that matters.515
  • Taurine has the most human trial data, but the proven effects are modest changes in blood pressure, triglycerides and insulin resistance. Whether it slows aging is unresolved.12
  • The mouse-to-human dose conversion for taurine (about 2.8-5.7 g) is described by Louis as a crude starting point for trials, not a recommendation.24
  • Do not buy NAD blood tests; the group's admins say blood NAD does not track age or tissue levels.56
  • Avoid combining nicotinic acid (niacin) with high-dose statins, per Louis.28
  • With creatine, people with cancer should discuss it with their oncology team, per the post that summarized the evidence.16
  • Evidence from small animal studies such as urolithin A and vanadyl sulfate is hypothesis-generating only.1011
  • Supplements with outcome-level randomized evidence (such as omega-3 and coenzyme Q10 in the 884-trial review) are a different category from the products above.12

Frequently asked questions

Does taurine slow aging in humans?

Not shown. Columbia's 2023 work suggested taurine deficiency drives aging in animals, but later studies found taurine does not consistently fall with age, and a Yale study found it rises. No human trial has tested lifespan effects.2417

What does taurine reliably do in trials?

Modest improvements in blood pressure, triglycerides, LDL, glucose and insulin resistance in pooled randomized trials. A diabetes trial using 3 g/day found improved insulin resistance and inflammation but no change in HbA1c, glucose or lipids.118

Are NMN and NR worth taking?

They raise NAD+ in blood, but the group's summaries say there is no convincing clinical evidence of slower aging. The best human signal in the pack is an NR trial in peripheral artery disease that improved walking distance over 6 months.529

Is creatine safe regarding cancer?

Animal data are mixed, and human data are reassuring but not definitive. A randomized trial in people with malignant cancer showed no survival difference, though it was not designed for that purpose.1636

Does urolithin A help the heart?

Mouse and engineered-tissue data suggest it might help heart failure with preserved ejection fraction, but human studies of that use are lacking.1019

Is spermidine proven to extend life?

In mice, yes in several studies; in people only observational associations exist.8

The evidence behind this summary48 studies · 4 meta-analyses · 11 trials · 9 observational

The 54 group posts cited above discuss 48 studies and sources. Their mix of study designs shows how much rests on randomized trials and meta-analyses, which can show cause and effect, and how much on observational, lab or animal work, which mostly cannot.

Meta-analyses 4Randomized trials 11Observational studies 9Reviews & guidelines 6Animal & lab studies 15Other sources 3

Strongest evidence discussed

All 48 studies and sources
Sources from the group (54)
  1. Taurine lowered blood pressure, LDL, glucose and insulin resistance in a meta-analysis Louis Nervegna · May 20, 2026 · Facebook
  2. Nature study challenges the idea that taurine declines with age Louis Nervegna · Jun 07, 2025 · Facebook
  3. Taurine is not a reliable aging biomarker, says new multi-species study Louis Nervegna · Jun 07, 2025 · Facebook
  4. Yale: blood taurine is central to controlling age-related inflammation (inflammaging) Louis Nervegna · Oct 25, 2026 · Facebook
  5. Blood NAD levels do not fall with age, so commercial NAD blood tests are useless Louis Nervegna · Oct 24, 2026 · Facebook
  6. Blood NAD+ is a useless aging biomarker: stable across seven cohorts (Nature Metabolism) Louis Nervegna · May 14, 2026 · Facebook
  7. Pilot: 20 g/day creatine raised brain creatine 11% in Alzheimer's patients Louis Nervegna · Jun 20, 2025 · Facebook
  8. Spermidine linked to lower mortality and cognitive decline, and longer lifespan in animals Gokhan Can · Mar 16, 2024 · Facebook
  9. Glycine 5 g three times daily lowered A1C from 8.3 to 6.9 in type 2 diabetes Louis Nervegna · Apr 06, 2026 · Facebook
  10. Urolithin A, a pomegranate gut metabolite, improved HFpEF in mice and human heart tissue Louis Nervegna · Aug 20, 2026 · Facebook
  11. Vanadyl sulfate cleared senescent cells and extended male mouse lifespan 7.4% Louis Nervegna · Nov 12, 2026 · Facebook
  12. Review of 884 supplement RCTs: omega-3, folic acid and CoQ10 helped; beta-carotene harmed Louis Nervegna · Nov 30, 2023 · Facebook
  13. Meta-analysis of 34 RCTs: taurine supplements improved several cardiometabolic markers Louis Nervegna · Feb 26, 2026 · Facebook
  14. Meta-analysis of 9 RCTs: taurine lowered insulin and triglycerides in overweight adults Louis Nervegna · Aug 07, 2026 · Facebook
  15. Whole-blood NAD+ does not change with age or lifestyle, so it is a poor aging marker Louis Nervegna · May 22, 2026 · Facebook
  16. Creatine and cancer metastasis: preclinical signal, but human evidence is reassuring Louis Nervegna · Sep 18, 2026 · Facebook
  17. Taurine deficiency may drive aging; Columbia study spans worms, mice, monkeys and humans Louis Nervegna · Mar 01, 2024 · Facebook
  18. Taurine 3 g/day lowered insulin, HOMA-IR and inflammation in type 2 diabetes RCT Louis Nervegna · Jul 04, 2026 · Facebook
  19. Urolithin A improved heart function up to 80% in mouse models of stiff-heart failure Louis Nervegna · Sep 30, 2026 · Facebook
  20. Taurine does not simply fuel cancer, argues a shared explainer Louis Nervegna · Jan 27, 2026 · Facebook
  21. A personal 'cocktail of metabolites' for longevity: AKG, arginine, beta-alanine, taurine Gokhan Can · May 12, 2024 · Facebook
  22. Yale: taurine loss triggers NLRP3 inflammasome; raising taurine eased inflammaging in mice Louis Nervegna · Nov 06, 2026 · Facebook
  23. Taurine lowers age-related inflammation via the NLRP3 inflammasome in mouse macrophages Louis Nervegna · Oct 27, 2026 · Facebook
  24. Mouse taurine doses of 500-1000 mg/kg scale to about 2.8-5.7 g for a 70 kg human Louis Nervegna · Oct 26, 2026 · Facebook
  25. Taurine 1.5 g/day for 2 weeks reversed endothelial dysfunction in type 1 diabetes Louis Nervegna · Apr 04, 2026 · Facebook
  26. Taurine and cardiovascular disease: anti-inflammatory and vascular effects Gokhan Can · Jan 27, 2024 · Facebook
  27. Taurine and heart health: promotional summary of blood pressure and insulin findings Louis Nervegna · Oct 25, 2026 · Facebook
  28. Niacin inhibited vascular calcification in mice via SIRT1/SIRT6 activation Louis Nervegna · Dec 09, 2025 · Facebook
  29. Nicotinamide riboside improved walking distance in PAD in a 6-month trial Louis Nervegna · Feb 14, 2026 · Facebook
  30. NAD+ boosting increased plaque and inflammation in Apoe knockout mice Gokhan Can · Apr 10, 2025 · Facebook
  31. Vitamin B3 (nicotinamide) shows early promise for protecting retinal cells in glaucoma Louis Nervegna · Nov 02, 2026 · Facebook
  32. Nicotinamide plus pyruvate improved visual-field function in glaucoma in a phase 2 trial Louis Nervegna · Oct 26, 2026 · Facebook
  33. Vitamin B3 users with high eye pressure were about two-thirds less likely to get glaucoma Louis Nervegna · Jul 15, 2026 · Facebook
  34. Niacin in a small glioblastoma pilot study: long survival, but historical controls Louis Nervegna · Feb 14, 2026 · Facebook
  35. Creatine 20 g/day improved cognition in Alzheimer's patients by nearly 5% in 8 weeks Louis Nervegna · Sep 22, 2025 · Facebook
  36. UCLA mouse study: creatine may boost cancer-fighting immune cells Louis Nervegna · Jul 15, 2026 · Facebook
  37. Animal study: creatine may help diet-related fatty liver but not alcohol-related Louis Nervegna · May 17, 2025 · Facebook
  38. Natto: spermidine, vitamin K2 and nattokinase in one food, with mortality and plaque data Gokhan Can · Dec 09, 2023 · Facebook
  39. Whole wheat contains spermidine, an autophagy-triggering molecule removed by refining Gokhan Can · Feb 08, 2026 · Facebook
  40. Whole grain paradox: GI similar to refined grains, yet lower disease risk; spermidine? Louis Nervegna · Jun 19, 2026 · Facebook
  41. Urolithin A overview: gut-made pomegranate metabolite, mostly preclinical heart evidence Louis Nervegna · Oct 14, 2026 · Facebook
  42. Urolithin A from pomegranate, walnuts and berries acts as a mild mitochondrial stressor Louis Nervegna · Dec 09, 2025 · Facebook
  43. Glycine may be geroprotective and protective against CVD, per a narrative review Louis Nervegna · Dec 28, 2025 · Facebook
  44. Glutathione supplements are probably a bad idea long term Louis Nervegna · Jul 04, 2026 · Facebook
  45. Nattokinase 10,800 FU/day improved carotid plaque and lipids; 3,600 FU/day did not Gokhan Can · Nov 17, 2023 · Facebook
  46. Nattokinase and PAI-1: how it may work and why PAI-1 matters Gokhan Can · Dec 03, 2023 · Facebook
  47. Aged garlic extract slowed coronary calcium progression in three small RCTs Gokhan Can · Nov 17, 2023 · Facebook
  48. Gotu kola extract reportedly stabilized high-risk plaque in small studies Louis Nervegna · Nov 17, 2023 · Facebook
  49. Centella asiatica and pine bark extract: small trials on arterial plaque stability Gokhan Can · Nov 17, 2023 · Facebook
  50. Testosterone for anti-aging lacks proven longevity benefit; high levels tied to deaths Louis Nervegna · Mar 23, 2024 · Facebook
  51. Neutering adult male mice extended lifespan over 30%, doubting testosterone as anti-aging Louis Nervegna · Nov 04, 2026 · Facebook
  52. All magnesium forms, even oxide, are absorbed; form-specific marketing is hype Louis Nervegna · Apr 14, 2026 · Facebook
  53. Magnesium: intake targets, widespread inadequacy and health roles (FoundMyFitness summary) Gokhan Can · Mar 19, 2024 · Facebook
  54. Rhonda Patrick on micronutrient deficiencies and exercise for healthy aging Gokhan Can · Mar 08, 2024 · Facebook

Keep exploring

Related research summaries

Topics and hashtags in this summary